Sort
30,917 grants matching “tumor microenvironment”
TECH Core
$583,074Kevin William Eliceiri · University Of Minnesota · U54 · FY2025 · CA
Developing a Human in Mouse Cancer Model with a Completely Humanized Stroma
$583,011Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2019 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
$582,940Mary L. Disis · University Of Washington · R01 · FY2009 · CA
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
$582,917Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2018 · CA
Uncovering treatment targets for peripheral nerve sheath tumor progression in NF1
$582,915David Andrew Largaespada · University Of Minnesota · R01 · FY2021 · NS
Phase II Clinical Development of Galectin-3 Inhibition and Anti-PD-1: Immune Monitoring and Tumor Response
$582,888Brendan D Curti · Providence Portland Medical Center · R01 · FY2023 · CA
Overcoming hypoxic resistance to anti-cancer therapy
$582,714Nicholas C Denko · Ohio State University · R01 · FY2025 · CA
Overcoming hypoxic resistance to anti-cancer therapy
$582,714Nicholas C Denko · Ohio State University · R01 · FY2021 · CA
Verteporfin as a YAP/TAZ inhibitor for treatment of glioblastoma
$582,634Renee D Read · Emory University · R01 · FY2025 · NS
Regulating the glioma immune microenvironment
$582,561Joanna Phillips · University Of California, San Francisco · R01 · FY2024 · NS
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$582,523Kim Butts Pauly · Stanford University · R01 · FY2022 · CA
IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY
$582,458Amer M Najjar · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
$582,405Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM
$582,392Harriet M Kluger · Yale University · K12 · FY2023 · CA
Glycosylation and Immune Evasion in Urologic Tumors
$582,341Sharon Pitteri · Stanford University · U01 · FY2021 · CA
Targeting cell regulatory states to complement MEK/autophagy inhibition in pancreatic cancer
$582,311Kenneth P Olive · Columbia University Health Sciences · R01 · FY2025 · CA
Designer Cytokine Therapy of Hepatocellular Carcinoma
$582,256Paul B Fisher · Virginia Commonwealth University · P01 · FY2025 · CA
Modulation of the tumor microenvironment with probiotic therapies
$582,197Tal Danino · Columbia Univ New York Morningside · R01 · FY2021 · CA
IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY
$582,093Amer M Najjar · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse
$581,811Svetomir Nenad Markovic · Mayo Clinic Rochester · R01 · FY2024 · CA
Stimulation of Tumorigenesis by NKG2D
$581,772Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Immune Regulation in the Microenvironment of Oropharyngeal Cancer
$581,720Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Immune Regulation in the Microenvironment of Oropharyngeal Cancer
$581,720Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Immune Regulation in the Microenvironment of Oropharyngeal Cancer
$581,720Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Molecular Roles of TGF-beta Signaling in Salivary Glands and Oral Cancer
$581,649Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE